Emerging Issues in FDA Law: Implementation of DQSA

December 3, 2014
Arnold & Porter LLP
Washington, DC

This one-day conference focuses on the Drug Quality and Security Act and its two major issue areas: implementation of track and trace procedures and regulation of pharmacy compounding. The program brings together government workers, consultants and industry representatives to discuss implementation, FDA guidance and future considerations. With guidance from expert speakers, participants will review the key parts of the act, recently released guidance from the FDA, implementation deadlines, and look ahead to future deadlines. The Drug Quality and Security Act will continue to have a significant impact on drug manufacturers, wholesalers and pharmacies. Join us to learn about specific requirements for all stakeholders throughout the drug distribution supply chain. 

Who Will Attend

  • Attorneys, regulatory staff and compliance personnel who work for drug manufacturers, pharmacies, third party distributors, warehouses and distribution facilities. 
  • Regulatory and other scientists who work in pharmacy compounding
  • Academics, consultants and other research organizations and the press who study and report on issues related to drug safety and pharmacy compounding.  

Meet the Speakers

Abraham Gitterman
Senior Associate
Arnold & Porter
Subscribe Link

Email Disclaimer